Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | MBRX | ATHE | ONVO | ||
Company | Moleculin Biotech CS | Alterity Therapeutics Ltd ADR | Organovo Holdings | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 4.50 | 2.26 | 0.9881 | ||
High | 4.90 | 2.75 | 1.0256 | ||
Low | 4.41 | 2.26 | 0.9801 | ||
Last | 4.63 | 2.51 | 1.0000 | ||
Change | +0.32 | +0.25 | +0.0119 | ||
% Change | +7.47% | +11.06% | +1.20% | ||
Volume | 24,000 | 87,800 | 139,300 | ||
20-Day Average Volume | 24,725 | 181,020 | 2,907,915 | ||
Previous Close | 4.31 | 2.26 | 0.9881 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 4.81 | 2.15 | 1.0603 | ||
20-Day Raw Stochastic | 19.34% | 51.08% | 2.63% | ||
20-Day Relative Strength | 39.51% | 58.77% | 46.58% | ||
Weighted Alpha | -60.12 | -41.13 | -57.84 | ||
Today's Opinion | 100% Sell | 24% Buy | 80% Sell | ||
Previous Opinion | 100% Sell | Hold | 80% Sell | ||
Last Month's Opinion | 72% Sell | 64% Sell | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -0.43% since 04/19/24 | +23.04% since 04/19/24 | -9.09% since 04/19/24 | ||
Low | 4.28 on 04/25/24 | 2.00 on 04/22/24 | 0.9800 on 04/25/24 | ||
High | 4.90 on 04/26/24 | 2.75 on 04/26/24 | 1.1200 on 04/22/24 | ||
1-Month | |||||
%Chg | -1.07% since 03/26/24 | +39.44% since 03/26/24 | -4.76% since 03/26/24 | ||
Low | 4.28 on 04/25/24 | 1.77 on 03/27/24 | 0.9800 on 04/25/24 | ||
High | 6.23 on 03/28/24 | 3.19 on 04/12/24 | 1.7400 on 04/15/24 | ||
3-Month | |||||
%Chg | -36.49% since 01/26/24 | +26.13% since 01/26/24 | -1.97% since 01/26/24 | ||
Low | 4.28 on 04/25/24 | 1.55 on 02/23/24 | 0.8911 on 02/09/24 | ||
High | 10.35 on 03/11/24 | 3.19 on 04/12/24 | 1.7400 on 04/15/24 | ||
6-Month | |||||
%Chg | -36.75% since 10/26/23 | +10.06% since 10/26/23 | -10.71% since 10/26/23 | ||
Low | 4.28 on 04/25/24 | 1.55 on 02/23/24 | 0.8911 on 02/09/24 | ||
High | 15.75 on 01/03/24 | 5.41 on 12/04/23 | 2.0500 on 11/07/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 10,313 | 11,723 | 10,040 | ||
Shares Outstanding, K | 2,227 | 4,671 | 10,040 | ||
Annual Sales | 0 | 0 | 370,000 | ||
Annual Net Income | -29,770,000 | -9,290,000 | -17,260,000 | ||
Last Quarter Sales | 0 | 119,159 | 10,000 | ||
Last Quarter Net Income | -10,270,000 | -1,749,580 | -3,600,000 | ||
60-Month Beta | 1.95 | 0.94 | 0.91 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.85 on 11/13/23 | N/A | -0.40 on 02/08/24 | ||
Latest Earnings Date | 05/09/24 | 10/02/20 | 02/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |